Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

Predictors of adequate percutaneous liver biopsy specimens: a single-center experience

The Egyptian Journal of Internal Medicine volume 31, pages 222–225 (2019)Cite this article

Abstract

Background

Percutaneous liver biopsy is one of the widely accepted procedures to find any disorder, infection, and disease. Understanding the correlation between biopsy factors and adequacy rate will improvize efficacy and safety of biopsy.

Objectives

This study was carried out to find the effect of needle size on the adequacy rate of biopsy and also to establish the association of factors such as BMI, cumulative length, and the number of cores to adequacy rate of biopsy.

Materials and methods

This retrospective review study was carried out at King Abdul-Aziz Medical City, MNGHA, Jeddah, Saudi Arabia. The data were acquired on adult patients who underwent percutaneous liver biopsy for 2010–2016 time periods. The data were analyzed by using the statistical package for social sciences, version 23.

Results

No significant difference was observed in the adequacy rate of biopsy among samples of different needles (P=0.998). Similarly, BMI and guidance did not significantly (P=0.860 and 0.873) affect the adequacy rate. However, the number of cores (P<0.001) and cumulative length (P<0.001) had a significant effect on adequacy rate. Finally, only cumulative length (2.4 cm) was significantly correlated (P<0.05) to the adequacy rate of Percutaneous liver biopsy (PLB).

Conclusion

The adequacy rate significantly depends on cumulative length and the number of cores. However, further studies are required to establish a conclusive relationship between factors and adequacy rate.

References

  1. Center for Disease Control and Prevention. National vital statistics reports 1999-2013. Available at: www.cdc.gov/nchs/products/nvsr.htm. [Accessed on 2018 Jul 26]

  2. Myers RP, Fong A, Shaheen AAM. Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies. Liver Int 2008; 28:705–712.

    Article  Google Scholar 

  3. Gilmore I, Burroughs A, Murray-Lyon I, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36:437–441.

    Article  CAS  Google Scholar 

  4. Bedossa P, Poynard T, Naveau S, Martin E, Agostini H, Chaput J. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12:173–178.

    Article  CAS  Google Scholar 

  5. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97:2614–2618.

    Article  Google Scholar 

  6. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344:495–500.

    Article  CAS  Google Scholar 

  7. Alswat KA, Mumtaz K, Jafri W. Liver biopsy for histological assessment: the case in favor. Saudi J Gastroenterol 2010; 16:133–139.

    Article  Google Scholar 

  8. Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006; 125:710–721.

    Article  Google Scholar 

  9. Fryer E, Wang LM, Verrill C, Fleming K. How often do our liver core biopsies reach current definitions of adequacy? J Clin Pathol 2013; 66:1087–1089.

    Article  Google Scholar 

  10. Cholongitas E, Burroughs AK. Is it difficult to obtain an optimal liver biopsy specimen? Hepatology 2010; 51:355–356.

    Article  Google Scholar 

  11. Demetris A, Ruppert K. Pathologist’s perspective on liver needle biopsy size? J Hepatol 2003; 39:275–277.

    Article  CAS  Google Scholar 

  12. Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int 2007; 27:1166–1173.

    Article  Google Scholar 

  13. Schulman AR, Thompson CC, Odze R, Chan WW, Ryou M. Optimizing EUS-guided liver biopsy sampling: comprehensive assessment of needle types and tissue acquisition techniques. Gastrointest Endosc 2017; 85:419–426.

    Article  Google Scholar 

  14. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14:3396.

    Article  Google Scholar 

  15. Judmaier G, Prior C, Klimpfinger M, Bernklau E, Vogel W, Dietze O, et al. Is percutaneous liver biopsy using the Trucut (Travenol) needle superior to Menghini puncture? Z Gastroenterol 1989; 27:657–661.

    CAS  PubMed  Google Scholar 

  16. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45(Suppl 4):IV1–IV11.

    PubMed  PubMed Central  Google Scholar 

  17. Harwood J, Bishop P, Liu H, Nowicki M. Safety of blind percutaneous liver biopsy in obese children a retrospective analysis. J Clin Gastroenterol 2010; 44:e253–e 255.

    Article  Google Scholar 

  18. Liu B, Balkwill A, Reeves G, Beral V. Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ 2010; 340: c912.

    Article  Google Scholar 

  19. Tublin ME, Blair R, Martin J, Malik S, Ruppert K, Demetris A. Prospective study of the impact of liver biopsy core size on specimen adequacy and procedural complications. Am J Roentgenol 2018; 210:183–188.

    Article  Google Scholar 

  20. Parkash O, Mumtaz K, Ahmed Z, Hamid S, Jafri F, Jafri W. Size or the number of portal tracts: which matters in a liver biopsy core in chronic hepatitis C? J Coll Physicians Surg Pak 2011; 21:121–122.

    PubMed  Google Scholar 

  21. Coral GP, Antunes ADP, Serafini APA, Araujo FB, Mattos AAD. Liver biopsy: importance of specimen size in the diagnosis and staging of chronic viral hepatitis. Rev Inst Med Trop São Paulo 2016; 58:10.

    Article  Google Scholar 

  22. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39:239–244.

    Article  Google Scholar 

  23. Schiano TD, Azeem S, Bodian CA, Bodenheimer HC, Merati S, Thung SN, et al. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005; 3:930–935.

    Article  Google Scholar 

  24. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1449–1457.

    Article  Google Scholar 

  25. Vuppalanchi R, Ünalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7:481–486.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, King Abdul-Aziz University, 9515, Jeddah, 21423, Saudi Arabia

    Shahad M. Alharbi MBBS & Asma D. Zaidan

  2. Department of Medicine, King Saud Bin Abdul-Aziz University for Health Sciences (KSAU-HS), Jeddah, Saudi Arabia

    Ahmed A. Aljuffri

  3. Department of Pediatrics, King Abdul-Aziz Medical City-Jeddah, National Guard Health Affairs, Jeddah, Saudi Arabia

    Ghassan A. Sukkar

  4. Department of Pathology, King Abdul-Aziz Medical City-Jeddah, National Guard Health Affairs, Jeddah, Saudi Arabia

    Hatem Q. Almaghrabi

Authors
  1. Shahad M. Alharbi MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asma D. Zaidan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed A. Aljuffri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ghassan A. Sukkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hatem Q. Almaghrabi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahad M. Alharbi MBBS.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alharbi, S.M., Zaidan, A.D., Aljuffri, A.A. et al. Predictors of adequate percutaneous liver biopsy specimens: a single-center experience. Egypt J Intern Med 31, 222–225 (2019). https://doi.org/10.4103/ejim.ejim_67_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_67_18

Keywords